Re: Sabizabulin - mCRPC- used now for Covid 19.
in response to
by
posted on
Apr 24, 2022 11:14AM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Yes, I see what you're saying. For me, I rather wait and see what will develop with one or two of the collaborators that are ongoing, to prove ZEN-3694 works while under Zenith's watch before a sell of.
Selling off the business the way things stand for Zenith at present, will not fetch much for investors. Especially when the SPP for "ZHCLF" on the OTC sells for $0.16 US. We need to take Zenith to a respectable level before a sell of.
IMO ... Koo